News · 26 weeks63+160%
2026-04-192026-10-11
Mix2790d
- Insider15(56%)
- SEC Filings4(15%)
- Other3(11%)
- Analyst2(7%)
- Earnings2(7%)
- Dividends1(4%)
Latest news
25 items- PRZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENTMulti-Year Extension to Help Accelerate Adoption of Wireless, Handheld TMINI® System for Use with Zimmer Biomet's Persona® Knee System FREMONT, Calif. and WARSAW, Ind., Oct. 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced a multi-year extension of its Limited Exclusive Distribution and Supply Agreement following a successful partnership during the initial term of the agreement. Under the extension, Zimmer Biomet will continue to distribute an exclusive version of THINK's wireless, handheld TMINI Miniature Robotic System over a multi
- ANALYSTBarclays initiated coverage on Zimmer Biomet with a new price targetBarclays initiated coverage of Zimmer Biomet with a rating of Equal Weight and set a new price target of $100.00
- PRZimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial ResultsWARSAW, Ind., Oct. 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its third quarter earnings conference call will be webcast on Wednesday, November 4, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET.A live audio webcast can be accessed via Zimmer Biomet's Investor Relations website at https://investor.zimmerbiomet.com. It will be available for replay following the conference call.Individuals in the U.S. and Canada who wish to dial into the conference call may do so by dialing (800) 330-6710 and using conference ID 7090861. International callers
- INSIDERSEC Form 4 filed by Zimmer Biomet Holdings Inc.4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 3 filed by Zimmer Biomet Holdings Inc.3 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 3 filed by Zimmer Biomet Holdings Inc.3 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Farrell Michael J.4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Hagemann Robert4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Higgins Arthur J4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Shapiro Louis4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Hilado Maria Teresa4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Kurdikar Devdatt4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERSEC Form 4 filed by Director Kolli Sreelakshmi4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDERGrp Pres-Global Business Thornal Kevin R sold $528,978 worth of shares (5,691 units at $92.95), closing all direct ownership in the company (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- INSIDEROfficer Phipps Chad F sold $295,050 worth of shares (3,000 units at $98.35), decreasing direct ownership by 4% to 65,231 units (SEC Form 4)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- PRZimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial TransformationGary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and DataWARSAW, Ind., Sept. 8, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced leadership appointments designed to streamline its Americas and Global Business Group organizations for greater focus and agility. Effective October 1, Gary Campbell will be promoted to President, Americas, and Brian Hatcher will be promoted to President, Recon, S.E.T., CMFT, Neuro an
- PRZimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026. The cash dividend of $0.24 per share is payable on or about October 30, 2026 to stockholders of record as of the close of business on September 30, 2026. About Zimmer BiometZimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.SCHEDULE 13G/A - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Subject)
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- INSIDERSEC Form 4 filed by President, APAC Desai Chintan4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
- SECSEC Form 10-Q filed by Zimmer Biomet Holdings Inc.10-Q - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- SECZimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Filer)
- PRZimmer Biomet Announces Second Quarter 2026 Financial ResultsSecond quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant currency1 basis and 4.0% on an organic constant currency1 basisSecond quarter diluted earnings per share were $1.03, an increase of 33.8%; adjusted1 diluted earnings per share were $2.07, consistent with the prior year periodCompany updates full-year 2026 financial guidanceWARSAW, Ind., Aug. 5, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE:ZBH) and (SIX: ZBH) today reported financial results for the quarter ended June 30, 2026. The Company reported second quarter net sales of $2.177 billion, an increase of 4.8% over the prior year period, an increase of 4.7% on a constant currency1 ba
- INSIDERGrp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)4 - ZIMMER BIOMET HOLDINGS, INC. (0001136869) (Issuer)
ZBH FAQ
6 questionsWhat does Zimmer Biomet Holdings Inc. do?
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the...Where does ZBH stock trade?
Zimmer Biomet Holdings Inc. (ZBH) is listed on NYSE.What sector and industry is ZBH in?
Zimmer Biomet Holdings Inc. operates in the Health Care sector, Industrial Specialties industry.What are analysts saying about ZBH?
Zimmer Biomet Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight on 2026-10-07.What companies are similar to ZBH?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), MAS (Masco Corporation), AIT (Applied Industrial Technologies Inc.). Compare ZBH side-by-side with any of them on Quantisnow.How can I track ZBH on Quantisnow?
Quantisnow aggregates Zimmer Biomet Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZBH to receive live email and push alerts on every new disclosure.